The potential reclassification of cannabinoids, particularly at the federal level, is generating considerable anticipation within the market. A shift away from Schedule I status, often considered as outdated and https://mollyzwbd578517.homewikia.com/11962086/cannabinoid_rescheduling_a_expansion_catalyst